An immune biomarker associated with EMT serves as a predictor for prognosis and drug response in bladder cancer
Figure 8.WDHD1-related drug molecular effects. (A) Drug sensitivity analysis of various drugs. (B) Visualization of drug-gene interactions. (C) WDHD1-upset.